See more : Nagambie Resources Limited (NAG.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Daito Chemix Corporation (4366.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Daito Chemix Corporation, a leading company in the Chemicals industry within the Basic Materials sector.
- Azitra, Inc. (AZTR) Income Statement Analysis – Financial Results
- Whitestone REIT (WSR) Income Statement Analysis – Financial Results
- KSS Limited (KSERASERA.NS) Income Statement Analysis – Financial Results
- Healthcare Solutions Management Group, Inc. (VRTY) Income Statement Analysis – Financial Results
- Yew Bio-Pharm Group, Inc. (YEWB) Income Statement Analysis – Financial Results
Daito Chemix Corporation (4366.T)
About Daito Chemix Corporation
Daito Chemix Corporation manufactures and sells specialty and fine chemicals in Japan. It offers photosensitive materials for LCD and semiconductor production. The company also provides printing and photographic materials, functional materials, pharmaceutical intermediates, and other chemical products. In addition, it engages in recycling and disposal business for industrial wastes and chemicals. The company was founded in 1938 and is headquartered in Osaka, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 15.81B | 16.38B | 16.13B | 14.00B | 12.42B |
| Cost of Revenue | 13.91B | 13.94B | 13.21B | 11.50B | 10.55B |
| Gross Profit | 1.90B | 2.44B | 2.93B | 2.50B | 1.87B |
| Gross Profit Ratio | 12.02% | 14.87% | 18.15% | 17.87% | 15.05% |
| Research & Development | 1.13B | 1.15B | 1.10B | 1.00B | 980.00M |
| General & Administrative | 152.00M | 147.00M | 170.00M | 171.00M | 167.00M |
| Selling & Marketing | 54.00M | 61.00M | 64.00M | 56.00M | 54.00M |
| SG&A | 1.03B | 1.04B | 1.05B | 964.00M | 948.00M |
| Other Expenses | -1.04B | 29.00M | 43.00M | 49.00M | 0.00 |
| Operating Expenses | 1.12B | 1.15B | 1.17B | 1.06B | 1.25B |
| Cost & Expenses | 15.04B | 15.09B | 14.37B | 12.55B | 11.80B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 39.00M | 27.00M | 21.00M | 20.00M | 21.00M |
| Depreciation & Amortization | 1.48B | 798.00M | 597.00M | 602.00M | 658.00M |
| EBITDA | 839.00M | 2.08B | 2.36B | 2.05B | 1.47B |
| EBITDA Ratio | 5.31% | 13.02% | 14.88% | 13.29% | 11.85% |
| Operating Income | 776.00M | 1.28B | 1.76B | 1.44B | 813.00M |
| Operating Income Ratio | 4.91% | 7.83% | 10.93% | 10.31% | 6.55% |
| Total Other Income/Expenses | -1.45B | 8.00M | -12.00M | -212.00M | -176.00M |
| Income Before Tax | -678.00M | 1.29B | 1.75B | 1.23B | 636.00M |
| Income Before Tax Ratio | -4.29% | 7.88% | 10.85% | 8.79% | 5.12% |
| Income Tax Expense | 327.00M | 368.00M | 168.00M | 139.00M | 112.00M |
| Net Income | -1.01B | 922.00M | 1.58B | 1.09B | 524.00M |
| Net Income Ratio | -6.36% | 5.63% | 9.81% | 7.80% | 4.22% |
| EPS | -93.62 | 85.96 | 147.50 | 101.75 | 48.81 |
| EPS Diluted | -93.62 | 85.96 | 147.50 | 101.75 | 48.81 |
| Weighted Avg Shares Out | 10.74M | 10.74M | 10.74M | 10.74M | 10.74M |
| Weighted Avg Shares Out (Dil) | 10.74M | 10.74M | 10.74M | 10.74M | 10.74M |
Source: https://incomestatements.info
Category: Stock Reports